Patient Numbers Dutasteride (N = 3,305) Placebo (N = 3,424) Relative Risk
Resource n Percentage (95% CI) n Percentage (95% CI) Estimate 95% CI
Concomitant Medications 841 25 (24, 27) 994 29 (28, 31) 1.14 1.05, 1.23
Alpha-blockers 713 22 (20, 23) 862 25 (24, 27) 1.17 1.07, 1.27
Health Care Visits            
Surgical procedures 60 2 (1, 2) 188 5 (5, 6) 3.02 2.27, 4.03
Nonsurgical procedures 5 0 (0, 0) 12 0 (0, 1) 2.32 0.82, 6.57
Unscheduled biopsies 322 10 (9, 11) 470 14 (13, 15) 1.41 1.23, 1.61
UTI 186 6 (5, 6) 299 9 (8, 10) 1.55 1.30, 1.85
AUR 53 2 (1, 2) 230 7 (6, 8) 4.19 3.12, 5.62
Macroscopic hematuria 114 3 (3, 4) 171 5 (4, 6) 1.45 1.15, 1.83
Macroscopic hematospermia 43 1 (1, 2) 35 1 (1, 1) 0.79 0.50, 1.22
AUR = acute urinary retention; CI = confidence interval; UTI = urinary tract infection. aTable presents the proportions of patients within each treatment group who experience at least one episode of each resource.
Table 3: Number and Proportion of Resource Events or Procedures by Treatment Groupa.